Pathogenic MYH7 mutations were identified in families with both dilated cardiomyopathy and anthracycline-associated cardiomyopathy, suggesting a shared genetic predisposition.
No takes yet. Share an insight, caveat, or question.
MYH7 variants may signal shared predisposition to anthracycline toxicity in DCM families; hypothesis-generating, requires validation before any screening change.
Wasielewski et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: